The video game EndeavorRX by developer Akili Interactive has received official approval from the USA Food and Drug Administration.

EndeavorRX can now be prescribed as a medication for children with Attention Deficit Disorder (ADHD). The effectiveness of the game in the treatment of SPAU was confirmed by clinical studies involving more than 600 children aged 8-12 years, which lasted seven years. Studies have confirmed that at least a third of children after playing EndeavorRX “did not show a measurable attention deficit disorder.”

EndeavorRX is a three-dimensional platformer for iPad and iPhone, where the player needs to move through the levels and collect items. The FDA notes that playing EndeavorRX 25 minutes a day five times a week for a month helps treat inactivity and attention deficit disorder.